Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06595407 · ClinicalTrials.gov registry record
Loss of Y Chromosome in Aortic Stenosis
A clinical trial of Aortic Stenosis, sponsored by University of Virginia.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT06595407 is a study of Aortic Stenosis that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 200 participants, below the 1,355-participant average among 26 other Aortic Stenosis trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06595407, a study of Aortic Stenosis, is actively recruiting participants, sponsored by University of Virginia.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The most common heart valve disease in humans is aortic stenosis which is a critical narrowing of the valve through which the heart has to pump blood to the rest of the body. This condition occurs in 2-3% of adults over 65 years of age and when it progresses to a severe stage leads to heart failure and need for valve replacement procedures (including surgery and catheter-based replacement). Aortic stenosis has a strong male predominance. The purpose of this study is to evaluate whether loss of Y-chromosome from circulating blood cells in males, which has been associated with TGF-beta-related fibrosis of other organs, is associated with the development of aortic stenosis.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Blood analysis for loss-of-Y chromosome
Study Locations (1)
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-08-15 |
| Est. Completion | 2026-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06595407
The ClinicalTrials.gov registry entry for NCT06595407 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,355-participant average among 26 other Aortic Stenosis trials with a reported enrollment target (85% lower). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aortic Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Blood analysis for loss-of-Y chromosome is the first listed.
NCT06595407 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT06595407 about?
NCT06595407 is a clinical study titled "Loss of Y Chromosome in Aortic Stenosis". The most common heart valve disease in humans is aortic stenosis which is a critical narrowing of the valve through which the heart has to pump blood to the rest of the body. This condition occurs in 2-3% of adults over 65 years of age and when it progresses to a severe stage leads to heart failure ...
What is the current status of trial NCT06595407?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2024-08-15. Estimated completion is 2026-06-01.
What conditions does trial NCT06595407 study?
This clinical trial studies the following conditions: Aortic Stenosis.
What interventions are being tested in trial NCT06595407?
The interventions under investigation include: Blood analysis for loss-of-Y chromosome (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06595407?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06595407 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
RECRUITING · Phase 2
-
Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
RECRUITING
-
Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis
RECRUITING · NA
-
Comparative Imaging Assessment of Valvular Heart Disease
RECRUITING
-
Novel Characterization of Sex Specific Biologic Signatures in Valvular Heart Disease
RECRUITING
-
Evaluating Infrasonic Hemodynography
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.